The company GR. SARANTIS S.A., in accordance with article 4.1.3.1. of the Athens Stock Exchange Regulation and article 10, par. 1 of L. 3340/2005, informs that the special tax audit for GR. SARANTIS S.
Sarantis Group will release the H1 2014 consolidated financial results, according to the following schedule: Wednesday July 30th 2014 after ASE closing – Results Release, which will be available in the Athens Stock Exchange web page (www.
ΑΝNOUNCEMENT Following the decision of the Board of Directors and in accordance with the article 22 of the Articles of Association, our Company’s shareholders are invited to the Ordinary General Shareholders’ Meeting on Thursday, June 26th 2014, at 14:00, at 26 Amaroussiou – Halandriou Street.
On 09/07/2014, Wednesday and at 16:00 p.m., the A’ Repeated Ordinary General Shareholders’ Meeting of “GR. SARANTIS S.A.” took place at the company’s registered offices. During the General Meeting, shareholders representing 24,527,297 shares were present, corresponding to a 70.
Following its announcement dated 15/10/2013 regarding the production transfer of face and body cream products ELMIPLANT, BIOTEN and KOLASTYNA from Romania to the Group’s production plant at Oinofoita, Greece, Sarantis Group announces that the production transfer was successfully completed within the first half of 2014.
Sarantis Group completed the acquisition of the Czech cosmetic trademarks company ASTRID T.M. More specifically, in the context of further strengthening its geographical footprint within the region of its operation and further enriching its own brand portfolio Sarantis Group signed an agreement for the acquisition of the 100% of the share capital of the company ASTRID T.
WELL POSITIONED FOR FURTHER FUTURE GROWTH,FURTHER GROSS PROFIT MARGIN IMPROVEMENT, MAINTENANCE OF NET CASH POSITIONFY 2014 GUIDANCE SUSTAINED Sarantis Group First Quarter 2014 financial results reflect an improvement in terms of sales across all regions.